Veterinary Medicines

Zeronil 402 mg Spot-on Solution for extra large dogs

Not authorised
  • Fipronil
Download as PDF

Product identification

Medicine name:
Zeronil 402 mg Spot-on Solution for extra large dogs
Active substance:
  • Fipronil
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Fipronil
    402.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX15
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Luxembourg
Package description:
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 150 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 90 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 60 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 30 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 24 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 21 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 20 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 18 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 15 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 12 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 10 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 9 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 8 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 6 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 4 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 3 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 2 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 1 pipette in individual foil sachets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Ministry Of Health And Social Security
Authorisation number:
  • IE/V/0276/004
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0276/004